Literature DB >> 26507209

The amount and duration of smoking is associated with aggravation of hormone and biochemical profile in women with PCOS.

Dimitrios Xirofotos1, Eftihios Trakakis1, Moli Peppa2, Charalambos Chrelias1, Pericles Panagopoulos1, Chrysi Christodoulaki1, Dimos Sioutis1, Dimitrios Kassanos1.   

Abstract

We investigated the association between the amount and duration of smoking on biochemical, clinical parameters and the ovarian morphology in women with polycystic ovary syndrome (PCOS). That was a retrospective study. These women were divided into two groups, non-smokers (217) and smokers (92). The amount of cigarettes and duration of smoking was measured in pack-years. Both groups underwent clinical evaluation, biochemical and hormone analysis, transvaginal ultrasound and oral glucose tolerance tests (OGTT). The mean value of the number of cigarettes was 14.8 (±8.8) and the median value of pack-years in the smokers group was 4.0 (1.5-7.5). Smokers group has significantly higher free testosterone (F-T), 17-hydroxyprogesterone (17-OHP), delta 4 androstenedione (Δ4-A), T4, low-density lipoprotein (LDL), and white blood cells (WBC). During correlation of all the above parameters and pack-years, there has been significant positive correlation in F-T and Δ4-A. The participants with more pack-years showed statistically higher values of F-T and Δ4-A. There was also a significant positive correlation between total cholesterol, triglycerides, WBC and pack-years of the participants. Prolactin (PRL) has been inversely associated with pack-years. We concluded that the increase of pack-years aggravated lipid profile, WBC and decreased PRL levels, in PCOS patients.

Entities:  

Keywords:  Biochemical profile; PCOS women; hormones; smoking

Mesh:

Year:  2015        PMID: 26507209     DOI: 10.3109/09513590.2015.1101440

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  5 in total

Review 1.  Smoke, alcohol and drug addiction and female fertility.

Authors:  Cristina de Angelis; Antonio Nardone; Francesco Garifalos; Claudia Pivonello; Andrea Sansone; Alessandro Conforti; Carla Di Dato; Felice Sirico; Carlo Alviggi; Andrea Isidori; Annamaria Colao; Rosario Pivonello
Journal:  Reprod Biol Endocrinol       Date:  2020-03-12       Impact factor: 5.211

2.  The Association Between Prolactin and Metabolic Parameters in PCOS Women: A Retrospective Analysis.

Authors:  Haiyan Yang; Junbo Di; Jiexue Pan; Rong Yu; Yili Teng; Zhuhua Cai; Xiaohui Deng
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-12       Impact factor: 5.555

Review 3.  Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review.

Authors:  Sarantis Livadas; Panagiotis Anagnostis; Julia K Bosdou; Dimitra Bantouna; Rodis Paparodis
Journal:  World J Diabetes       Date:  2022-01-15

4.  Metabolic Concomitants of Obese and Nonobese Women With Features of Polycystic Ovarian Syndrome.

Authors:  Jocelyne Matar Boumosleh; Scott M Grundy; Jennifer Phan; Ian J Neeland; Alice Chang; Gloria Lena Vega
Journal:  J Endocr Soc       Date:  2017-11-02

5.  Suitability of the National Health Care Surveys to Examine Behavioral Health Services Associated with Polycystic Ovary Syndrome.

Authors:  Ninive Sanchez
Journal:  J Behav Health Serv Res       Date:  2018-04       Impact factor: 1.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.